Home miR Scientific LLC.

miR Scientific LLC.

miR Scientific Notes Validation of its Urine Based, Non-Invasive Prostate Cancer Test Is Published in the Journal of Urology

MiR Scientific notes the data show that miR Scientific's platform can detect molecular evidence of prostate cancer with sensitivity of 94% and specificity of 92%, which translates to AUC of 0.98.